Fucose sugar may help prevent liver cancer from spreading

8733b6be-35c4-4eae-820f-af5db470ea4farticleimage.jpg

13 Oct 2017 --- Researchers at the RIKEN Global Research Cluster in Japan have discovered a way in which fucose sugar can prevent the spread of cancer in the liver. Published in the journal Cell Chemical Biology, the study details how treatment with a modified fucose sugar can disrupt a biological pathway, which in turn blocks hepatoma – cancer cells in the liver – from invading healthy liver cells.

Many important biological functions depend on a process called glycosylation, which is the attachment of sugars to other molecules such as proteins, lipids, or other sugars. When the sugar fucose (Fuc) is attached to a chain of sugars called glycans, they are said to be fucosylated.

“Fucosylated glycans are critical in several cellular processes that affect development and immunity,” says first author Yasuhiko Kizuka. “At the same time, defective fucosylation can lead to life-threatening diseases.”

One such disease is liver cancer, in which hepatoma are known to have excessive levels of fucosylated glycans. The RIKEN team reasoned that treatment targeting fucosylation in these cells might be effective in treating cancer.

Strategy for fucosylation
Biological pathways are chains of events in which a series of molecules interact with each other step by step, usually with the help of enzymes. In this case, several events transform glucose into a compound called GDP-fucose. An enzyme then detaches fucose from GDP and joins it to a glycan.

One way to inhibit this type of biological signaling process is to introduce molecular analogs – molecules that are similar to those needed in the chain of interactions.

The team at RIKEN used this strategy and compared the effects of two fucose analogs on fucosylation. Using several different types of cells, they found that one of them, 6-Alk-Fuc, virtually abolished all cellular fucosylation.

The next step was to determine how fucosylation was blocked. Experiments showed that the analog did not prevent the transfer of fucose from GDP-fucose to glycans, indicating that fucosylation itself was not affected.

The team reasoned that the effect must occur earlier in the chain of events. Additional experiments showed that 6-Alk-Fuc blocked GDP-mannose from becoming GDP-fucose.

As Kizuka explains: “The analog competed with GDP-mannose for attention from the enzyme FX, which prevented fucose from being made from GDP-fucose, making it impossible for downstream fucosylation to occur.”

With this knowledge in hand, the team was able to test whether the 6-Alk-Fuc has the potential to treat liver cancer. Using several cell lines of a hematoma that had excessive levels of fucosylated glycans, the team found that the analog was able to prevent healthy extracellular matrix from being invaded by the hepatoma, and was able to suppress migration of some hepatoma cell lines.

However, while it suppressed invasion, the treatment did not suppress hepatoma proliferation, meaning that the number of cancer cells continued to increase, even though they could not harm the healthy cells.

Kizuka says that the invasion-suppressive properties of this fucose analog make it a potentially promising treatment for suppressing cancer metastasis in Fuc-high cancers such as those found in the liver.

Related Articles

Nutrition & Health News

Taking iron supplements every other day may help with absorption

20 Oct 2017 --- A study has found that in iron-depleted women, providing iron supplements daily as divided doses increases serum hepcidin and reduces iron absorption. According to the results, providing iron supplements on alternate days and in single doses optimizes iron absorption and might be a preferable dosing regimen.

Nutrition & Health News

Obesity’s many risks may include worsening asthma in children

20 Oct 2017 --- Obesity has been found to be a risk factor for repeated hospital admissions among children in Japan hospitalized for asthma, researchers report in a Pediatric Allergy & Immunology study. Asthma and obesity are common chronic illnesses and public health problems for children in developed countries like Japan. The prevalence of asthma and obesity is increasing, and the study authors note that several studies reported an association between obesity and asthma in children.

Food Ingredients News

Taiyo’s Sunfiber earns Monash University’s Low FODMAP Certification

20 Oct 2017 --- Nutritional ingredient company Taiyo has announced that its premium branded ingredient Sunfiber is the first fiber and first standalone ingredient to become a Monash University Low FODMAP Certified product. Sunfiber, made from guar bean, is also one of the only soluble fiber ingredients approved by the FDA in 2016 to be listed as a dietary fiber.

Nutrition & Health News

Satiety: Mushrooms may trump meat in helping to feel fuller for longer

19 Oct 2017 --- If breakfast is the most important meal of the day, then a new Mushroom Council-funded study suggests mushrooms may be one of the most important ingredients. The study on satiety, published in the October issue of the journal Appetite, indicates that eating a mushroom-rich breakfast may result in less hunger and a greater feeling of fullness after a mushroom breakfast compared to a meat breakfast.

Nutrition & Health News

Health claims on snack bar packaging lead to better consumer sensory acceptance: study

19 Oct 2017 --- A study looking into the influence of package and health-related claims on perception and sensory acceptability of snack bars has found that when health claims were given to consumers, a better sensory acceptance was observed. Among other findings, package attributes, price and flavor were also highlighted on purchase intention of bars.

More Articles
URL : http://www.nutritioninsight.com:80/news/fucose-sugar-may-help-prevent-liver-cancer-from-spreading.html